Dear everyone, I want to tell you that there are actually only five Chinese medicine stocks that can really continue to strengthen in the A** market. The rest, you can completely ignore. So, what kind of Chinese medicine stocks can become long-term leaders? There are two key criteria here.
First of all, we are looking for important stocks that have deep institutional involvement. The pharmaceutical industry, I have to say, is the most difficult of all industries to study. It is difficult for the average investor to understand the doorway. But there is a rule that you can't go wrong by following the pace of the institution.
Secondly, we need to pay attention to Chinese medicine stocks with high gross profit margins. From past historical cases, we can see that many pharmaceutical giants, such as Hengrui and Pien Tze Huang, have gross profit margins of more than 50%.
Based on the above two points, we find that only five Chinese medicine stocks in all A-shares are truly worth holding for a long time. In particular, it is worth mentioning the last of these five, whose company's products have been proven to have a significant effect on the ** new crown. Recently, a number of institutions have collectively increased their positions, expressing high optimism about their prospects.
So, who exactly are these five amazing companies? Don't worry, I'll reveal it for you. Let's look forward to their brilliant performances!
The fifth Zhongsheng PharmaceuticalThe gross profit margin is 66%, and among the top ten shareholders, there are social security, Hong Kong, settlement seal No. 1, etcFourth, Zhongheng GroupAmong the top ten shareholders with a gross profit margin of 72%, there are ** Huijin Bosera CSI E Fund, etcThe third Kangyuan PharmaceuticalAmong the top ten shareholders with a gross profit margin of 75%, there are Gaoyi Capital, **Huijin Bosera** and so onThe second 100 pharmaceuticalAmong the top ten shareholders with a gross profit margin of 78%, there are Jinyuan, Shun An**, Société Générale JPMorgan Chase and so onThe first one has great potential, gross profit margin of 73%, the top ten shareholders include Gaoyi Capital, GF steady growth**, two pensions**.
(The last one, with a small envelope like one, sends a 178, and shows it immediately, not Pingloon District).